Xeris Biopharma Holdings Inc logo

Xeris Biopharma Holdings Inc

STU:2B30 (USA)   Ordinary Shares
€ 3.23 (+0.62%) Nov 28
At Loss
Market Cap:
€ 486.97M ($ 514.74M)
Enterprise V:
€ 677.81M ($ 716.46M)
Volume:
-
Avg Vol (2M):
463.00
Trade In:

Xeris Biopharma Holdings Inc Valuation Measures